Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Teva Pharmaceuticals

Epinephrine Auto-Injector Companies to Face Off Against Affordability Legislation in Court

The End of an Era: What the EpiPen Patent Expiration Means...

A Conversation About neffy, the World’s First Needle-Free Emergency Epinephrine Alternative

Pharma Company Pushes Back on State’s Efforts to Make Epinephrine Affordable

Pfizer Will Pay $50M to Settle EpiPen Antitrust Claims

Viatris — Formerly Mylan — Agrees to $264 Million Settlement to...

Ruling Allows Millions to Join Lawsuit in EpiPen Racketeering Case

A Guide to Emergency Epinephrine Options in the US (Including Usage...

Teva Announces Availability of a Generic Equivalent of EpiPen Jr® Auto-Injector...

Sanofi Seeking Billions from Mylan in EpiPen Antitrust Suit

Follow Us

Your School On Our Map

Put Your School on the Map